Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Tandem Diabetes Care (TNDM) over the last 11 years, with Q3 2025 value amounting to -$9.3 million.

  • Tandem Diabetes Care's Change in Account Payables fell 68206.2% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year decrease of 15248.83%. This contributed to the annual value of -$2.4 million for FY2024, which is 5082.24% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Change in Account Payables stood at -$9.3 million, which was down 68206.2% from -$898000.0 recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Change in Account Payables high stood at $10.5 million for Q1 2021, and its period low was -$9.3 million during Q3 2025.
  • Over the past 3 years, Tandem Diabetes Care's median Change in Account Payables value was -$1.0 million (recorded in 2024), while the average stood at $569250.0.
  • Over the last 5 years, Tandem Diabetes Care's Change in Account Payables had its largest YoY gain of 29700.21% in 2025, and its largest YoY loss of 68206.2% in 2025.
  • Quarter analysis of 3 years shows Tandem Diabetes Care's Change in Account Payables stood at $10.5 million in 2021, then tumbled by 113.67% to -$1.4 million in 2024, then crashed by 547.92% to -$9.3 million in 2025.
  • Its Change in Account Payables was -$9.3 million in Q3 2025, compared to -$898000.0 in Q2 2025 and $6.6 million in Q1 2025.